Overview

HP 129Xe MRI for Evaluation of CLAD in Lung Transplant Recipients

Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the feasibility of hyperpolarized 129Xe MRI in lung transplant recipients and assess structural and functional pulmonary changes using hyperpolarized 129Xe MRI
Phase:
Phase 2
Details
Lead Sponsor:
The Hospital for Sick Children
Collaborator:
University Health Network, Toronto
Treatments:
Xenon